Suchergebnisse - "Mc Laughlin, Anna M"

PubPharm (9)

1

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort

enthalten in: Clinical pharmacology and therapeutics | 2024

von Mc Laughlin, A. | Helland, T. | Klima, F. | +74

2

TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors : Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Colombo, I. | Koster, K. | Holer, L. | +15

3

Model-informed drug development of autologous CAR-T cell therapy : Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling

enthalten in: CPT: pharmacometrics & systems pharmacology | 2023

von Mc Laughlin, A. | Milligan, P. | Yee, C. | +1

4

Letter to the editor : Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy

enthalten in: Journal for immunotherapy of cancer | 2023

von Mc Laughlin, A. | Yee, C.

CommentOn: J Immunother Cancer. 2022 Dec;10(12):. - PMID 36600553

5

Model‐informed drug development of autologous CAR‐T cell therapy : Strategies to optimize CAR‐T cell exposure leveraging cell kinetic/dynamic modeling

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2023

von Mc Laughlin, A. | Milligan, P. | Yee, C. | +1

6

Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS

enthalten in: Journal of pharmaceutical and biomedical analysis | 2022

von Opitz, P. | Zimmermann, S. | Mc Laughlin, A. | +7

7

Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias : protocol for a systematic review

enthalten in: BMJ open | 2022

von van Dyk, M. | Boylan, C. | Michelet, R. | +11

8

Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs : The ON-TARGET Study Protocol

enthalten in: Cancers | 2021

von Mc Laughlin, A. | Schmulenson, E. | Teplytska, O. | +17

9

Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer : protocol for a systematic review

enthalten in: BMJ open | 2021

von van Dyk, M. | Bulamu, N. | Boylan, C. | +6

1
[1]